# Trade Mark Journal No.2026/030 24 July 2026

## WO0000001927203 (5)

Office of origin: United States of America

Date of International Registration:11 June 2026
Date of designation in the UK: 11 June 2026

International priority date claimed: 6 January 2026 (United States of America) (99580732)

Class 5
  Pharmaceutical preparations for the treatment of allergies and allergic diseases and disorders, autoimmune diseases and disorders, dermatological diseases and disorders, damaged skin and tissues, gastrointestinal diseases and disorders, inflammation and inflammatory diseases and disorders, respiratory diseases and disorders.

Connect Biopharma Holdings Limited

Representative: Jessica L. Rothstein Goodwin Procter LLP, 620 Eighth Avenue, New York NY 10018, UNITED STATES OF AMERICA